A Phase II Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma.
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 23 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Sep 2005 New trial record.